Immune cells in Alzheimer’s disease: insights into pathogenesis and potential therapeutic targets
Authors:
Open Access
- 23 December 2024
- journal article
- research article
- Published by Walter de Gruyter GmbH in Medical Review
- Vol. 5 (3) , 179-202
Abstract
Alzheimer’s disease (AD) is a chronic neurodegenerative disorder for which there are currently no effective treatment options. Increasing evidence suggests that AD is a systemic disease closely associated with the immune system, not merely a central nervous system (CNS) disorder. Immune cells play crucial roles in the onset and progression of AD. Microglia and astrocytes are the primary inflammatory cells in the brain that can sensitively detect changes in the internal environment and transform into different phenotypes to exert differing effects at various stages of AD. Peripheral immune cells, such as T cells, B cells, monocytes/macrophages, and neutrophils can also be recruited to the CNS to mediate the inflammatory response in AD. As such, investigating the role of immune cells in AD is particularly important for elucidating its specific pathogenesis. This review primarily discusses the roles of central innate immune cells, peripheral immune cells, and the interactions between central and peripheral immune cells in the development of neuroinflammation in AD. Furthermore, we listed clinical trials targeting AD-associated neuroinflammation, which may represent a promising direction for developing effective treatments for AD in the future.Keywords
Funding Information
- The Beijing Municipal Administration of Hospitals' Ascent Plan
- Beijing Brain Initiative from Beijing Municipal Science & Technology Commission (Z201100005520016)
- National Natural Science Foundation of China (81870825, 82071194)
- STI2030-Major Projects (Grant No.2022ZD0211600, 2022ZD0211605)
- Natural Science Foundation of Beijing Municipality (7202061)
This publication has 220 references indexed in Scilit:
- Deletion of Alzheimer's disease‐associated CD33 results in an inflammatory human microglia phenotypeGlia, 2021
- ABCA7 and the altered lipidostasis hypothesis of Alzheimer's diseaseAlzheimer's & Dementia, 2020
- Anti‐interleukin‐17A and anti‐interleukin‐23 antibodies may be effective against Alzheimer's disease: Role of neutrophils in the pathogenesisBrain and Behavior, 2019
- CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A reviewJournal of Cellular Physiology, 2018
- Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 CarriersJAMA Network Open, 2018
- The role and therapeutic potential of monocytic cells in Alzheimer's diseaseGlia, 2010
- Neuroprotective role of microglia expressing interleukin‐4Journal of Neuroscience Research, 2005
- Microglial activation and dopamine terminal loss in early Parkinson's diseaseAnnals of Neurology, 2005
- Costimulatory Effects of Interferon-γ and Interleukin-1β or Tumor Necrosis Factor α on the Synthesis of Aβ1-40 and Aβ1-42 by Human AstrocytesNeurobiology of Disease, 2000
- Interleukin-10, interleukin-4, and transforming growth factor-? differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cellsGlia, 2000